Plaid, a fintech unicorn known for its APIs that connect consumer bank accounts to financial applications, announced today that it is buying Cognito.The price is around $250 million, paid in a ...

(Cognito Therapeutics) The Hope study will task upwards of 400 people with mild to moderate Alzheimer’s with using the noninvasive device at home every day for 12 months, throughout which they ...

Kern sees potential for Cognito’s headset to be a standalone therapy or used alongside new Alzheimer’s drugs that target amyloid and which modestly slow the worsening of the disease.

Cognito’s headset uses light and sound therapy to stimulate gamma waves. Cognito Therapeutics The device, which looks like a blend of sunglasses and headphones, emits pulsing lights and sounds.

J ust as a new wave of approved drugs for Alzheimer’s disease reaches patients, medical device company Cognito Therapeutics has raised a fresh $35 million to advance its alternative treatment ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cognito Therapeutics, a neurotechnology company advancing disease-modifying therapies to treat CNS diseases, announced today a $73M Series B financing round led ...

The series B round adds $73 million to Cognito’s coffers, the startup announced Wednesday. It’ll go toward the ongoing pivotal study of the noninvasive headset, which relies on light waves and ...